NPI registry status
Active
2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1891290797 MD PHD
Verify on CMS → Rolake Alabi, MD PHD
Retina Specialist (Ophthalmology) Physician in Austin, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 913 in Retina Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
529
Medicare Part D claims · 176 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.9K
9 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Rolake Alabi, MD PHD filed 529 Medicare Part D claims in 2023 as a Retina Specialist (Ophthalmology) Physician in Austin, Texas, prescribing 66% generic.
- 529
- Part D claims, 2023
- 66%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Rolake Alabi, MD PHD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
529 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Rolake Alabi, MD PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Rolake Alabi, MD PHD?
Quality data not reportedPrimary specialty
Retina Specialist (Ophthalmology) Physician
Medicare Part D claims
529 5% vs specialty avg
Specialty distribution in Texas
How Retina Specialist (Ophthalmology) Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Retina Specialist (Ophthalmology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Rolake Alabi, MD PHD appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding MD PHD credentials at 801 W 38TH ST STE 200, Austin, TX, 78705, with a listed phone of (512) 451-0103. NPI 1891290797 was issued on 03/24/2018.
Medicare Part D records for calendar year 2023 show 529 prescription claims written by this provider, covering 176 Medicare beneficiaries and totaling roughly $26K in drug spend, split 34% brand-name and 66% generic by claim count.
Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1891290797 |
|---|---|
| Specialty | Retina Specialist (Ophthalmology) Physician |
| Credentials | MD PHD |
| Gender | Female |
| NPI Issued | 03/24/2018 |
Hospital and facility affiliations
Facilities where Rolake Alabi, MD PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Austin Retina Associates PLLC
Austin, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Rolake Alabi, MD PHD. Source: openpaymentsdata.cms.gov.
Total received
$1.9K
Largest payer
ABBVIE INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Rolake Alabi, MD PHD. To verify Rolake Alabi, MD PHD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Rolake Alabi, MD PHD - brand share 34.0%
Retina Specialist (Ophthalmology) Physician average
34% brand-name claims vs 66% generic, on 529 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
529
Total Claims
$26K
Total Drug Cost
176
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 778
- Total Day Supply
- 19,706
- Brand vs Generic
- 34% brand / 66% generic
- Brand Drug Cost
- $16K
- Generic Drug Cost
- $10K
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.30
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 28, 65-74: 77, 75-84: 60, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Rolake Alabi, MD PHD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Prednisolone Acetate
Prednisolone Acetate
148 claims
- Ofloxacin
Ofloxacin
75 claims
- Erythromycin
Erythromycin
71 claims
- Atropine Sulfate 57
Atropine Sulfate
57 claims
- Latanoprost 28
Latanoprost
28 claims
- Brimonidine Tartrate 24
Brimonidine Tartrate
24 claims
- Timolol Maleate 19
Timolol Maleate
19 claims
- Dorzolamide-Timolol 18
Dorzolamide-Timolol
18 claims
| Drug | Claims |
|---|---|
| Prednisolone Acetate | 148 |
| Ofloxacin | 75 |
| Erythromycin Erythromycin Base | 71 |
| Atropine Sulfate | 57 |
| Latanoprost | 28 |
| Brimonidine Tartrate | 24 |
| Timolol Maleate | 19 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 18 |
| Ketorolac Tromethamine | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Retina Specialist (Ophthalmology) Physician in TX →
All providers in Texas →
Compare specialties →
Retina Specialist (Ophthalmology) Physician Overview
How Rolake Alabi, MD PHD fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.
913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider
Rolake Alabi, MD PHD's 529 claims are below the specialty average of 558.
Nearby Retina Specialist (Ophthalmology) Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Alabi.
Dr. Matthew Adams
MD
Plano, TX
Dr. Hasenin Al-Khersan
MD
Bellaire, TX
Dr. Harshivinderjit Bains
MD
Tyler, TX
Dr. Touka Banaee
MD
Galveston, TX
Dr. Keith Bourgeois
M.D.
Houston, TX
Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Retina Specialist (Ophthalmology) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Rolake Alabi, MD PHD's specialty? ▼
Rolake Alabi, MD PHD specializes in Retina Specialist (Ophthalmology) Physician and practices in Austin, Texas. Credentials: MD PHD.
How much does Rolake Alabi, MD PHD prescribe under Medicare Part D? ▼
In 2023, Rolake Alabi, MD PHD wrote 529 Medicare Part D claims totaling $26K in drug costs for 176 beneficiaries.
Where is Rolake Alabi, MD PHD located? ▼
Rolake Alabi, MD PHD is located at 801 W 38TH ST STE 200, Austin, TX, 78705. Phone: (512) 451-0103.
What is Rolake Alabi, MD PHD's NPI number? ▼
Rolake Alabi, MD PHD's National Provider Identifier (NPI) is 1891290797, issued on 03/24/2018.
Does Rolake Alabi, MD PHD prescribe more brand-name or generic drugs? ▼
Rolake Alabi, MD PHD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $16K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US? ▼
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does Rolake Alabi, MD PHD prescribe most often? ▼
Based on 2023 Medicare Part D data, Rolake Alabi, MD PHD's most frequently prescribed drugs include Prednisolone Acetate, Ofloxacin, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Rolake Alabi, MD PHD accept Medicare? ▼
Rolake Alabi, MD PHD appears in CMS Medicare data with 529 Part D claims and 176 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Rolake Alabi, MD PHD's credentials? ▼
Rolake Alabi, MD PHD's NPI is 1891290797 with credentials MD PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.